Alexandra Kropotova - 19 Sep 2025 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Signature
Alexandra Kropotova
Issuer symbol
SABS
Transactions as of
19 Sep 2025
Net transactions value
$0
Form type
4
Filing time
22 Sep 2025, 17:00:04 UTC
Previous filing
28 Aug 2025
Next filing
24 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kropotova Alexandra CHIEF MEDICAL OFFICER 777 W 41ST, SUITE 401, MIAMI BEACH Alexandra Kropotova 22 Sep 2025 0001825323

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SABS Common Stock Tax liability -1,977 -4.2% 45,272 19 Sep 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's common stock ("Common Stock") withheld to satisfy tax withholding requirements on the vesting of the Issuer's restricted stock units ("RSUs").
F2 Includes 29,340 shares of Common Stock and 15,932 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended.
F3 Each RSU represents a contingent right to receive one share of Common Stock.